91. The viable disc tissue allograft supplementation (VAST) randomized controlled trial in patients with chronic discogenic low back pain: Correlating age with clinical outcome

MLA

Richard D. Guyer, et al. “91. The Viable Disc Tissue Allograft Supplementation (VAST) Randomized Controlled Trial in Patients with Chronic Discogenic Low Back Pain: Correlating Age with Clinical Outcome.” The Spine Journal, vol. 21, Sept. 2021, pp. S44–45. EBSCOhost, https://doi.org/10.1016/j.spinee.2021.05.116.

APA

Richard D. Guyer, Michael J. DePalma, Mark I. Froimson, J. Kenneth Burkus, & Corey W. Hunter. (2021). 91. The viable disc tissue allograft supplementation (VAST) randomized controlled trial in patients with chronic discogenic low back pain: Correlating age with clinical outcome. The Spine Journal, 21, S44–S45. https://doi.org/10.1016/j.spinee.2021.05.116

Chicago

Richard D. Guyer, Michael J. DePalma, Mark I. Froimson, J. Kenneth Burkus, and Corey W. Hunter. 2021. “91. The Viable Disc Tissue Allograft Supplementation (VAST) Randomized Controlled Trial in Patients with Chronic Discogenic Low Back Pain: Correlating Age with Clinical Outcome.” The Spine Journal 21 (September): S44–45. doi:10.1016/j.spinee.2021.05.116.